2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Keratosis, Actinic
29
Uterine Cervical Dysplasia
14
Carcinoma, Basal Cell
12
Melanoma
10
Glioma
6
Glioblastoma
6
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Neoplasm Metastasis
4
Keratosis
4
Condylomata Acuminata
4
Precancerous Conditions
3
Papillomavirus Infections
3
Hutchinson's Melanotic Freckle
3
Vulvar Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Intraepithelial Lesions
2
Non-Muscle Invasive Bladder Neoplasms
2
Neoplasms
2
Hemangioma, Capillary
2
HIV Infections
2
Ependymoma
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Warts
1
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Virus Diseases
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Interventions
pembrolizumab
24
Nivolumab
23
aldesleukin
21
Cyclophosphamide
20
Ipilimumab
17
Interleukin-2
17
fludarabine
15
fludarabine phosphate
14
cemiplimab
12
Radiotherapy
7
Fluorouracil
7
Biopsy
7
dabrafenib
6
Surveys and Questionnaires
6
Dacarbazine
6
trametinib
5
binimetinib
5
Vemurafenib
5
Temozolomide
5
Surgical Procedures, Operative
5
Sirolimus
5
Radiation
5
Blood Specimen Collection
5
Aminolevulinic Acid
5
sonidegib
4
encorafenib
4
Photochemotherapy
4
Mohs Surgery
4
HhAntag691
4
Educational Status
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Skin Neoplasms
×
Imiquimod
×
Clear all
NCT03534947
2025-12-16
SONIB
Melanoma Institute Australia
Phase 2
Completed
16 enrolled